Open AccessAnalysis of compensation policies for executives and directors of bio-pharmaceutical companies in the context of the global spread of COVID-19
Author(s) -
Linzhuo Lyu
Publication year - 2022
Publication title -
bcp business and management
Language(s) - English
Resource type - Journals
ISSN - 2692-6156
DOI - 10.54691/bcpbm.v28i.2224
Subject(s) - incentive , business , compensation (psychology) , context (archaeology) , cash , order (exchange) , accounting , covid-19 , executive compensation , marketing , corporate governance , economics , finance , infectious disease (medical specialty) , psychology , medicine , paleontology , disease , pathology , psychoanalysis , biology , microeconomics